Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C09CA04	ZIOREL	G	Irbesartan - 300mg	300mg	Tablet, film coated	575,933 L.L
C10AA07	ROVASTIN	G	Rosuvastatin (calcium) - 10mg	10mg	Tablet	618,168 L.L
D10AF01	MEDACIN T	G	Clindamycin (phosphate) - 10mg/ml	10mg/ml	Solution	314,459 L.L
G04CA02	MINGO	G	Tamsulosin - 0.4mg	0.4mg	Capsule	673,201 L.L
J01DD02	CEFTAZIDIME PANPHARMA	G	Ceftazidime (pentahydrate) - 1g	1g	Injectable powder for solution	3,300,477 L.L
J01RA	SPIRAGYL	G	Metronidazole - 125mg, Spiramycin - 750,000IU		Tablet, scored	474,824 L.L
L01AX03	TEMOZOLOMIDE GP PHARM	G	Temozolomide - 5mg	5mg	Capsule, hard	1,153,017 L.L
M02AA15	OLFEN	G	Diclofenac sodium (diethylamine) - 1%	1%	Gel	268,769 L.L
N05AH03	OLIZAX 10	G	Olanzapine - 10mg	10mg	Tablet, mouth dissolving	2,598,096 L.L
R03DA11	ANSIMAR	G	Doxofylline - 400mg	400mg	Tablet	544,256 L.L
A02BC01	AXIPRON	G	Omeprazole - 20mg	20mg	Capsule	373,358 L.L
A07EA02	HEMORRANE	G	Hydrocortisone acetate - 10mg/g	10mg/g	Ointment	710,893 L.L
B05CX01	DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	158,587 L.L
C05AA01	SEDIPROCT	G	Hydrocortisone - 5mg, Cinchocaine HCl - 5mg, Framycetin sulfate - 10mg, Esculoside - 10mg		Suppository	237,860 L.L
C10AA07	ROXARDIO	G	Rosuvastatin (calcium) - 10mg	10mg	Tablet, film coated	720,525 L.L
D10AF01	CLINIDERM	G	Clindamycin (phosphate) - 1%	1%	Gel	712,876 L.L
G04CA02	PROSTAFINE	G	Tamsulosin HCl - 0.4mg	0.4mg	Capsule, modified release	761,511 L.L
J01DD02	FORTECARE	G	Ceftazidime - 1g	1g	Injectable powder for solution	10,011,695 L.L
J01RA	SPIRAGYL FORTE	G	Metronidazole - 250mg, Spiramycin - 1,500,000IU		Tablet, scored	474,824 L.L
L01AX04	DACARBAZINE MEDAC	G	Dacarbazine - 200mg	200mg	Injectable powder for solution	15,866,076 L.L
M02AA15	VOLDIC	G	Diclofenac sodium (diethylamine) - 10mg/g	1%	Emulgel	172,012 L.L
N02BE01	PARACEROL	G	Paracetamol - 10mg/ml	10mg/ml	Injectable solution	1,536,012 L.L
N05AH03	PRANZA	G	Olanzapine - 10mg	10mg	Tablet, orodispersible	3,553,120 L.L
N06CA02	MELIXITE	G	Flupentixol (dihydrochloride) - 0.5mg, Melitracen (HCl) - 10mg		Tablet, film coated	600,250 L.L
R03DA55	CAMPHO-PNEUMINE AMINOPHYLLINE ENFANTS	G	Eucalyptol - 0.03g, Camphre - 0.04g, Gaiacol ethyl glycolate - 0.12g, Aminophylline - 0.06g		Suppository	284,127 L.L
S01ED51	DORZOLAMIDE/TIMOLOL BGR	G	Timolol maleate - 5mg/ml, Dorzolamide HCl - 20mg/ml		Drops solution	689,391 L.L
A02BC01	DIGCAP	G	Omeprazole - 20mg	20mg	Capsule	593,850 L.L
A10BK03	EMPAZA	G	Empagliflozin - 25mg	25mg	Tablet, film coated	1,740,724 L.L
B05CX01	DEXTROSE INJECTION 5%	G	Dextrose, H2O - 5g/100ml		Injectable solution	212,797 L.L
C05AA01	SINAHEAL-H	G	Hydrocortisone acetate - 5mg, Lidocaine - 60mg, Zinc oxide - 400mg, Aluminium Subacetate - 50mg		Suppository	501,253 L.L